Dr. Huang is a leading figure in both Computer-Aided Drug Design(CADD) and Artificial Intelligence-Driven Drug Design (AIDD) in China, providing scientific consulting services to AI-driven pharmaceutical companies such as XtalPi and DP Technology, as well as top Internet companies such as ByteDance, Baidu and Tencent, and conducting related research in collaboration with these companies.

Dr. Huang received his bachelor’s degree and master’s degree in physics at Tsinghua University, and his Ph.D. in chemistry at University of Basel in Switzerland.

Dr. Huang did his postdoctoral training from 2012 to 2017 in the Computer-Aided Drug Design Center in University of Maryland School of Pharmacy. In 2015 he was awarded a research contract from National Institute of Health (NIH), and thus held a joint appointment in the Laboratory of Computational Biology at the National Heart, Lung, and Blood Institute, NIH.